Convalescence clinical trials at UCSD

• Convalescent Plasma to Stem Coronavirus (CSSC-001)

  open to eligible people ages 18 years and up

  Evaluate the efficacy of treatment with high-titer Anti- SARS-CoV-2 plasma versus control (SARS-CoV-2 non-immune plasma) in subjects exposed to Coronavirus disease (COVID-19) at day 28.

  La Jolla, California and other locations

Last updated: November 6, 2020